CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.17 (-10.18%)
Close on Nov 17, 2026Market cap $22.68MP/E –Yield –
CervoMed total assets
Total assets on the balance sheet at the end of each period.
CervoMed's total assets was $25.99M at Jun 30, 2026. For fiscal 2025 it was $22.88M, down 46.9% from the year before. Over ten years it grew 26.0% a year on average. The highest annual figure on record is $43.08M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.88M | -46.9% |
| FY2024 | Dec 31, 2024 | $43.08M | +332.0% |
| FY2023 | Dec 31, 2023 | $9.97M | +139.9% |
| FY2022 | Dec 31, 2022 | $4.16M | -89.0% |
| FY2021 | Dec 31, 2021 | $37.84M | +36.5% |
| FY2020 | Dec 31, 2020 | $27.73M | +15.0% |
| FY2019 | Dec 31, 2019 | $24.11M | +32.5% |
| FY2018 | Dec 31, 2018 | $18.20M | -30.4% |
| FY2017 | Dec 31, 2017 | $26.15M | +49.5% |
| FY2016 | Dec 31, 2016 | $17.48M | +668.0% |
| FY2015 | Dec 31, 2015 | $2.28M | -94.7% |
| FY2014 | Dec 31, 2014 | $42.78M | +133.2% |
| FY2013 | Dec 31, 2013 | $18.34M | +649.9% |
| FY2012 | Dec 31, 2012 | $2.45M | -33.4% |
| FY2011 | Dec 31, 2011 | $3.67M | -34.1% |
| FY2010 | Dec 31, 2010 | $5.58M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $25.99M | -31.7% |
| Q1 FY2026 | Mar 31, 2026 | $15.11M | -60.8% |
| Q4 FY2025 | Dec 31, 2025 | $22.88M | -46.9% |
| Q3 FY2025 | Sep 30, 2025 | $30.61M | -37.4% |
| Q2 FY2025 | Jun 30, 2025 | $38.08M | -28.4% |
| Q1 FY2025 | Mar 31, 2025 | $38.58M | +382.4% |
| Q4 FY2024 | Dec 31, 2024 | $43.08M | +332.0% |
| Q3 FY2024 | Sep 30, 2024 | $48.88M | +306.1% |
| Q2 FY2024 | Jun 30, 2024 | $53.19M | +1481.1% |
| Q1 FY2024 | Mar 31, 2024 | $8.00M | +102.8% |
| Q4 FY2023 | Dec 31, 2023 | $9.97M | +139.9% |
| Q3 FY2023 | Sep 30, 2023 | $12.04M | -54.3% |
| Q2 FY2023 | Jun 30, 2023 | $3.36M | -88.5% |
| Q1 FY2023 | Mar 31, 2023 | $3.94M | -88.3% |
| Q4 FY2022 | Dec 31, 2022 | $4.16M | -89.0% |
| Q3 FY2022 | Sep 30, 2022 | $26.32M | -35.6% |
| Q2 FY2022 | Jun 30, 2022 | $29.18M | -44.6% |
| Q1 FY2022 | Mar 31, 2022 | $33.57M | -40.3% |
| Q4 FY2021 | Dec 31, 2021 | $37.84M | +36.5% |
| Q3 FY2021 | Sep 30, 2021 | $40.88M | +28.1% |
| Q2 FY2021 | Jun 30, 2021 | $52.71M | +46.4% |
| Q1 FY2021 | Mar 31, 2021 | $56.21M | +167.0% |
| Q4 FY2020 | Dec 31, 2020 | $27.73M | +15.0% |
| Q3 FY2020 | Sep 30, 2020 | $31.92M | +97.1% |
| Q2 FY2020 | Jun 30, 2020 | $35.99M | +90.1% |
| Q1 FY2020 | Mar 31, 2020 | $21.06M | +31.7% |
| Q4 FY2019 | Dec 31, 2019 | $24.11M | +32.5% |
| Q3 FY2019 | Sep 30, 2019 | $16.20M | -31.4% |
| Q2 FY2019 | Jun 30, 2019 | $18.93M | -36.8% |
| Q1 FY2019 | Mar 31, 2019 | $15.99M | -52.1% |
| Q4 FY2018 | Dec 31, 2018 | $18.20M | -30.4% |
| Q3 FY2018 | Sep 30, 2018 | $23.59M | -16.7% |
| Q2 FY2018 | Jun 30, 2018 | $29.94M | -11.7% |
| Q1 FY2018 | Mar 31, 2018 | $33.37M | -8.2% |
| Q4 FY2017 | Dec 31, 2017 | $26.15M | +49.5% |
| Q3 FY2017 | Sep 30, 2017 | $28.33M | +48.7% |
| Q2 FY2017 | Jun 30, 2017 | $33.91M | – |
| Q1 FY2017 | Mar 31, 2017 | $36.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $17.48M | – |
| Q3 FY2016 | Sep 30, 2016 | $19.05M | – |
See a number that looks wrong?